Business
Paradigm (ASX:PAR) share price shoots 30% higher on FDA update
Image source: Getty Images
The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price has returned from its trading halt and is charging higher on Wednesday.
At the time of writing, the biopharmaceutical company’s shares are up 30% to $2.69.
Why is the Paradigm share price charging higher?
…
Continue Reading
-
Noosa News22 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News20 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News20 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General18 hours agoDairy farmers devastated by floods across parts of New South Wales